Lumito
2.88 SEK
-2.21 %
Less than 1K followers
LUMITO
NGM Growth Market
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
-2.21 %
-15.32 %
-56.77 %
-58.93 %
-86.63 %
-96.13 %
-99.17 %
-99.15 %
-98.82 %
Lumito is a Swedish company that develops and markets systems for tissue and biomarker analysis in digital pathology, built on upconverting nanoparticle technology. The company targets healthcare facilities, research and the pharmaceutical sector. The company was formed in 2010 as a spinoff from a research group at Lund University's Department of Atomic Physics and Laser Center. Lumito is headquartered in Lund.
Read moreMarket cap
9.89M SEK
Turnover
41.98K SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue K
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
20.8
2026
Interim report Q2'26
29.10
2026
Interim report Q3'26
23.2
2027
Annual report '26
All
Press releases
ShowingAll content types
Invitation to webinar in connection with Lumito AB’s interim report for Q1 2026
Simpler biomarker workflows without compromising sensitivity: new white paper shows how researchers gain reproducible, quantitative IHC results in fewer steps
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools